HK Stock MarketDetailed Quotes
01332 TOUYUN BIOTECH
- 0.230
- 0.0000.00%
Market Closed May 2 16:08 CST
645.37MMarket Cap-2395P/E (TTM)
0.240High0.201Low160.63KVolume0.201Open0.230Pre Close37.04KTurnover0.01%Turnover RatioLossP/E (Static)2.81BShares0.68052wk High3.48P/B645.37MFloat Cap0.13152wk Low--Dividend TTM2.81BShs Float2.784Historical High--Dividend LFY16.96%Amplitude0.086Historical Low0.230Avg Price10000Lot Size--Div YieldTTM--Div Yield LFY
TOUYUN BIOTECH Key Stats
All
YOY
| (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -36.85%-272.59M | ---- | -61.98%-199.18M | ---- | 28.50%-122.97M | ---- | 11.76%-171.98M | ---- | 22.65%-194.9M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 34.22%-1.63M | ---- | -1,330.64%-2.48M | ---- | -16.11%-173K | ---- | 98.46%-149K | ---- | 15.99%-9.65M | ---- |
| Interest expense - adjustment | ---- | ---- | ---- | ---- | ---- | ---- | ---1.12M | ---- | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | ---- | ---- | ---- | 140.52%24.46M | ---- | -727.44%-60.36M | ---- |
| Impairment and provisions: | 1,145.84%98.47M | --0 | 228.31%7.9M | --0 | -189.34%-6.16M | --0 | -95.92%6.9M | --0 | 112.13%169.19M | --0 |
| -Impairment of property, plant and equipment (reversal) | --67.93M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairmen of inventory (reversal) | --14.52M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Impairment of trade receivables (reversal) | -68.62%2.48M | ---- | 1,607.13%7.9M | ---- | 70.22%463K | ---- | -91.53%272K | ---- | 59.23%3.21M | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 344.86%164.7M | ---- |
| -Other impairments and provisions | --13.54M | ---- | ---- | ---- | -200.00%-6.62M | ---- | 419.86%6.62M | ---- | --1.27M | ---- |
| Revaluation surplus: | -33.12%100.43M | --0 | 179.24%150.17M | --0 | -3.52%53.78M | --0 | 39.95%55.74M | --0 | 158.43%39.83M | --0 |
| -Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---- | -49.18%-273K | ---- | 94.17%-183K | ---- | -339.15%-3.14M | ---- |
| -Other fair value changes | -33.12%100.43M | ---- | 177.83%150.17M | ---- | -3.35%54.05M | ---- | 30.15%55.92M | ---- | 204.77%42.97M | ---- |
| Asset sale loss (gain): | -27.35%2.05M | --0 | -87.71%2.82M | --0 | 59.30%22.91M | --0 | 706.45%14.38M | --0 | 6.51%1.78M | --0 |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | 50.97%22.68M | ---- | --15.02M | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | -27.35%2.05M | ---- | 1,145.58%2.82M | ---- | 135.09%226K | ---- | -136.12%-644K | ---- | -25.24%1.78M | ---- |
| Depreciation and amortization: | 10.40%36.59M | --0 | 45.98%33.14M | --0 | -20.21%22.7M | --0 | -9.92%28.45M | --0 | 10.79%31.58M | --0 |
| -Depreciation | 13.87%36.3M | ---- | 54.07%31.88M | ---- | -1.52%20.69M | ---- | -11.14%21.01M | ---- | 14.41%23.65M | ---- |
| -Amortization of intangible assets | -77.55%282K | ---- | -37.42%1.26M | ---- | -73.01%2.01M | ---- | -6.28%7.44M | ---- | 1.24%7.94M | ---- |
| Financial expense | -65.68%7.43M | ---- | 26.30%21.65M | ---- | -46.18%17.14M | ---- | 22.56%31.85M | ---- | -37.84%25.99M | ---- |
| Special items | -22.18%5.21M | ---- | -58.60%6.7M | ---- | 446.24%16.18M | ---- | -135.87%-4.67M | ---- | 70.80%13.03M | ---- |
| Operating profit before the change of operating capital | -216.02%-24.03M | --0 | 508.91%20.72M | --0 | 121.06%3.4M | --0 | -197.98%-16.15M | --0 | 117.18%16.49M | --0 |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | 213.14%3.22M | ---- | -392.00%-2.85M | ---- | -55.50%975K | ---- | -71.62%2.19M | ---- | 165.60%7.72M | ---- |
| Accounts receivable (increase)decrease | -61.29%5.97M | ---- | 110.83%15.43M | ---- | -1,382.93%-142.48M | ---- | 10.22%11.11M | ---- | -26.65%10.08M | ---- |
| Accounts payable increase (decrease) | 58.17%-10.71M | ---- | -173.42%-25.6M | ---- | 186.97%34.87M | ---- | 222.95%12.15M | ---- | -235.17%-9.88M | ---- |
| Financial assets at fair value (increase)decrease | 149.94%19.25M | ---- | -50.01%7.7M | ---- | -67.13%15.4M | ---- | 134.83%46.87M | ---- | -1,090.19%-134.58M | ---- |
| Cash from business operations | 242.62%12.24M | 133.31%16.92M | 56.29%-8.58M | 63.21%-50.79M | -202.42%-19.63M | -398.79%-138.05M | 110.57%19.17M | 166.88%46.2M | -85.13%-181.43M | -4.41%-69.08M |
| Hong Kong profits tax paid | -68.17%-2.53M | ---- | ---1.51M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other taxs | ---- | ---- | ---- | 95.86%-141K | -228.74%-3.3M | -725.97%-3.4M | 135.32%2.56M | 92.62%-412K | -519.74%-7.25M | -2,749.49%-5.59M |
| Interest received - operating | -34.22%1.63M | -60.71%66K | 1,330.64%2.48M | -89.30%168K | 16.11%173K | 3,104.08%1.57M | -24.75%149K | -42.35%49K | -79.42%198K | -90.27%85K |
| Interest paid - operating | 59.02%-7.69M | 66.88%-3.74M | 39.59%-18.76M | 3.01%-11.3M | 16.57%-31.06M | -14.74%-11.65M | -126.13%-37.23M | -37.69%-10.15M | 12.94%-16.46M | 34.34%-7.37M |
| Special items of business | 177.33%18.54M | ---- | -135.16%-23.98M | ---- | 284.35%68.2M | ---- | 48.08%-37M | ---- | ---71.25M | ---- |
| Net cash from operations | 113.83%3.65M | 121.34%13.25M | 50.99%-26.37M | 59.05%-62.06M | -250.63%-53.81M | -524.55%-151.52M | 92.51%-15.35M | 143.55%35.69M | -74.99%-204.94M | -6.83%-81.95M |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | ---- | ---- | ---- | --167K | ---- | ---- | ---- | ---- | ---- | ---- |
| Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 136,700.00%10.93M | ---6K |
| Sale of fixed assets | 3.22%1.19M | ---- | -64.93%1.15M | -43.39%1.23M | 19.96%3.28M | 142.84%2.17M | 81.10%2.73M | 22,250.00%894K | -68.67%1.51M | -99.99%4K |
| Purchase of fixed assets | -32.51%-17.13M | 38.34%-1.16M | 92.09%-12.93M | 97.90%-1.88M | -30.27%-163.51M | -349.74%-89.29M | -3,326.51%-125.51M | -585.33%-19.85M | 86.61%-3.66M | 93.11%-2.9M |
| Purchase of intangible assets | ---- | ---- | ---- | ---- | ---87.28M | ---- | ---- | ---- | 55.10%-3.98M | 47.03%-3.04M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | --152.08M | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | --32.79M | ---- | ---- | ---- |
| Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | ---- | -78.94%42.12M | ---- | 66.67%200M | ---- |
| Cash on investment | -906.40%-55M | ---55M | 89.55%-5.47M | ---- | ---52.3M | ---27.3M | ---- | ---- | 59.27%-48.96M | ---48.96M |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --100M |
| Net cash from investment operations | -311.38%-70.95M | -11,551.04%-56.16M | 88.33%-17.25M | 99.58%-482K | -208.63%-147.74M | -503.48%-114.42M | -130.72%-47.87M | -142.04%-18.96M | 641.43%155.83M | 368.52%45.1M |
| Net cash before financing | -54.30%-67.3M | 31.38%-42.91M | 78.36%-43.62M | 76.48%-62.54M | -218.83%-201.55M | -1,689.62%-265.94M | -28.73%-63.22M | 145.40%16.73M | 66.34%-49.11M | 60.59%-36.85M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -65.77%112.88M | ---- | -3.67%329.81M | -96.41%3M | 2,481.79%342.37M | --83.58M | 19.13%13.26M | ---- | --11.13M | ---- |
| Refund | 39.43%-130.19M | -184.82%-35.76M | -66.89%-214.95M | --42.16M | -230.23%-128.8M | ---- | --98.9M | --2.9M | ---- | ---- |
| Issuing shares | -14.29%6M | ---- | -94.67%7M | ---- | 9.53%131.27M | -71.76%28.2M | --119.85M | --99.86M | ---- | ---- |
| Dividends paid - financing | ---- | ---- | ---- | ---- | ---92.88M | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | -14.35%-110.6M | ---- | -2,852.38%-96.72M | ---46.6M | 96.90%-3.28M | ---- |
| Other items of the financing business | 14.86%-16.37M | 17.05%-8.71M | -5.76%-19.23M | -111.48%-10.5M | -172.19%-18.18M | 1,322.64%91.49M | 266.64%25.18M | 194.78%6.43M | -545.58%-15.11M | -174.25%-6.79M |
| Net cash from financing operations | -126.97%-27.68M | -228.32%-44.47M | -16.68%102.63M | -82.95%34.66M | -23.25%123.17M | 224.75%203.27M | 2,311.27%160.47M | 1,022.52%62.59M | 93.29%-7.26M | -174.25%-6.79M |
| Effect of rate | -84.57%1.37M | -120.76%-566K | 330.17%8.89M | 184.51%2.73M | -181.68%-3.86M | -63.81%-3.23M | 785.07%4.73M | 31.36%-1.97M | -123.51%-690K | -192.49%-2.87M |
| Net Cash | -260.94%-94.98M | -213.45%-87.39M | 175.29%59.01M | 55.52%-27.88M | -180.59%-78.38M | -179.01%-62.67M | 272.54%97.26M | 281.79%79.32M | 77.82%-56.37M | 54.54%-43.64M |
| Begining period cash | 112.79%128.1M | 112.79%128.1M | -57.74%60.2M | -57.74%60.2M | 252.08%142.44M | 252.08%142.44M | -58.51%40.46M | -58.51%40.46M | -72.03%97.51M | -72.03%97.51M |
| Cash at the end | -73.07%34.49M | 14.55%40.15M | 112.79%128.1M | -54.21%35.05M | -57.74%60.2M | -35.03%76.54M | 252.08%142.44M | 130.96%117.81M | -58.51%40.46M | -80.06%51.01M |
| Cash balance analysis | ||||||||||
| Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg